Before the COVID-19 pandemic, leveraging digital technologies in medical product development seemed impossible with the industry’s patient recruitment, timeline, and success rate struggles. However the global lockdown forced researchers to reconsider, forever changing how clinical trials are conducted. For the first time ever, pharmaceutical and technology companies collaborated to develop common study standards and protocols. But this is just the start. Find out why this collaboration needs to continue to improve clinical trials beyond the pandemic.